Veroux M, Puliatti C, Macarone M, Cappello D, Gagliano M, Spataro M, Di Mare M, Giuffrida G, Veroux P
Department of Surgery, Transplantation and Advanced Technologies, Organ Transplant Unit, University Hospital, Catania, Italy.
Transplant Proc. 2005 Jul-Aug;37(6):2467-8. doi: 10.1016/j.transproceed.2005.06.011.
The success of renal transplantation as a treatment for end-stage renal disease has created a chronic shortage of donor organs. We present our initial experience in transplanting kidneys from hepatitis B surface antigen (HbsAg)-positive donors into HbsAg-positive recipients.
From January 2002 to March 2004, 5 patients with end-stage renal disease, hepatitis B virus (HBV) infection, and HbsAg seropositivity underwent a kidney transplantation from a cadaveric HbsAg-positive donor. The median time on the waiting list was 8 months, compared with the median of 3 years on the national waiting list.
One patient experienced an acute rejection; 1 patient had an increase in serum level of aspartate aminotransferase (AST)/alanine aminotransferase (ALT) with no signs of recurrence of hepatitis. Graft and patient survival at a median follow-up of 12 months was 100%.
Although the number of patients is small and the follow-up is short, our results suggest that HbsAg-positive donors can be considered as an alternative donor source because their kidneys are allocated to the matched serology-positive recipients, shortening their time on the waiting list.
Zotero 插件